Bladder Cancer in Exosomal Perspective: Unraveling New Regulatory Mechanisms

References

• Bray FF, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal AJ. Erratum: global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2020;70(4):313. doi:10.3322/caac.21609
   Web of Science ®Google Scholar
• Nawaz M, Camussi G, Valadi H, et al. The emerging role of extracellular vesicles as biomarkers for urogenital cancers. Nat Rev Urol. 2014;11(12):688–701. doi:10.1038/nrurol.2014.301
   PubMed Web of Science ®Google Scholar
• Grossman HB, Soloway M, Messing E, et al. Surveillance for recurrent bladder cancer using a point-of-care proteomic assay. JAMA. 2006;295(3):299–305. doi:10.1001/jama.295.3.299
   PubMed Web of Science ®Google Scholar
• Lotan Y, Roehrborn CG. Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses. Urology. 2003;61(1):109–118. doi:10.1016/S0090-4295(02)02136-2
   PubMed Web of Science ®Google Scholar
• Bellmunt J, de Wit R, Vaughn DJ, et al. Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma. N Engl J Med. 2017;376(11):1015–1026. doi:10.1056/NEJMoa1613683
   PubMed Web of Science ®Google Scholar
• He C, Zheng S, Luo Y, Wang B. Exosome Theranostics: biology and Translational Medicine. Theranostics. 2018;8(1):237–255. doi:10.7150/thno.21945
   PubMed Web of Science ®Google Scholar
• Milane L, Singh A, Mattheolabakis G, Suresh M, Amiji MM. Exosome mediated communication within the tumor microenvironment. J Control Release. 2015;219:278–294. doi:10.1016/j.jconrel.2015.06.029
   PubMed Web of Science ®Google Scholar
• Yang Y, Miao L, Lu Y, Sun Y, Wang S. Exosome, the glass slipper for Cinderella of cancer-bladder cancer? J Nanobiotechnology. 2023;21(1):368. doi:10.1186/s12951-023-02130-8
   PubMed Web of Science ®Google Scholar
• Doyle LM, Wang MZ. Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis. Cells. 2019;8(7):727. doi:10.3390/cells8070727
   PubMed Web of Science ®Google Scholar
• Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478). doi:10.1126/science.aau6977
   PubMed Web of Science ®Google Scholar
• Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200(4):373–383. doi:10.1083/jcb.201211138
   PubMed Web of Science ®Google Scholar
• Li A, Zhang T, Zheng M, Liu Y, Chen Z. Exosomal proteins as potential markers of tumor diagnosis. J Hematol Oncol. 2017;10(1):175. doi:10.1186/s13045-017-0542-8
   PubMedGoogle Scholar
• Harding C, Heuser J, Stahl P. Endocytosis and intracellular processing of transferrin and colloidal gold-transferrin in rat reticulocytes: demonstration of a pathway for receptor shedding. Eur J Cell Biol. 1984;35(2):256–263.
   PubMed Web of Science ®Google Scholar
• Sun Y, Liu S, Qiao Z, et al. Systematic comparison of exosomal proteomes from human saliva and serum for the detection of lung cancer. Anal Chim Acta. 2017;982:84–95. doi:10.1016/j.aca.2017.06.005
   PubMed Web of Science ®Google Scholar
• Zhang X, Bao L, Yu G, Wang H. Exosomal miRNA-profiling of pleural effusion in lung adenocarcinoma and tuberculosis. Front Surg. 2022;9:1050242. doi:10.3389/fsurg.2022.1050242
   PubMed Web of Science ®Google Scholar
• Andre F, Schartz NE, Movassagh M, et al. Malignant effusions and immunogenic tumour-derived exosomes. Lancet. 2002;360(9329):295–305. doi:10.1016/S0140-6736(02)09552-1
   PubMed Web of Science ®Google Scholar
• Pisitkun T, Shen RF, Knepper MA. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci U S A. 2004;101(36):13368–13373. doi:10.1073/pnas.0403453101
   PubMed Web of Science ®Google Scholar
• Street JM, Barran PE, Mackay CL, et al. Identification and proteomic profiling of exosomes in human cerebrospinal fluid. J Transl Med. 2012;10(1):5. doi:10.1186/1479-5876-10-5
   PubMedGoogle Scholar
• Keller S, Rupp C, Stoeck A, et al. CD24 is a marker of exosomes secreted into urine and amniotic fluid. Kidney Int. 2007;72(9):1095–1102. doi:10.1038/sj.ki.5002486
   PubMed Web of Science ®Google Scholar
• Minciacchi VR, Freeman MR, Di Vizio D. Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes. Semin Cell Dev Biol. 2015;40:41–51. doi:10.1016/j.semcdb.2015.02.010
   PubMed Web of Science ®Google Scholar
• Kalluri R, McAndrews KM. The role of extracellular vesicles in cancer. Cell. 2023;186(8):1610–1626. doi:10.1016/j.cell.2023.03.010
   PubMed Web of Science ®Google Scholar
• Muller L, Hong CS, Stolz DB, Watkins SC, Whiteside TL. Isolation of biologically-active exosomes from human plasma. J Immunol Methods. 2014;411:55–65. doi:10.1016/j.jim.2014.06.007
   PubMed Web of Science ®Google Scholar
• Zarovni N, Corrado A, Guazzi P, et al. Integrated isolation and quantitative analysis of exosome shuttled proteins and nucleic acids using immunocapture approaches. Methods. 2015;87:46–58. doi:10.1016/j.ymeth.2015.05.028
   PubMed Web of Science ®Google Scholar
• Yang D, Zhang W, Zhang H, et al. Progress, opportunity, and perspective on exosome isolation - efforts for efficient exosome-based theranostics. Theranostics. 2020;10(8):3684–3707. doi:10.7150/thno.41580
   PubMed Web of Science ®Google Scholar
• Konoshenko MY, Lekchnov EA, Vlassov AV, Laktionov PP. Isolation of Extracellular Vesicles: general Methodologies and Latest Trends. Biomed Res Int. 2018;2018:8545347. doi:10.1155/2018/8545347
   PubMed Web of Science ®Google Scholar
• Yu LL, Zhu J, Liu JX, et al. A Comparison of Traditional and Novel Methods for the Separation of Exosomes from Human Samples. Biomed Res Int. 2018;2018:3634563. doi:10.1155/2018/3634563
   PubMed Web of Science ®Google Scholar
• Gámez-Valero A, Monguió-Tortajada M, Carreras-Planella L, Franquesa M, Beyer K, Borràs FE. Size-Exclusion Chromatography-based isolation minimally alters Extracellular Vesicles’ characteristics compared to precipitating agents. Sci Rep. 2016;6:33641. doi:10.1038/srep33641
   PubMed Web of Science ®Google Scholar
• Li P, Kaslan M, Lee SH, Yao J, Gao Z. Progress in Exosome Isolation Techniques. Theranostics. 2017;7(3):789–804. doi:10.7150/thno.18133
   PubMed Web of Science ®Google Scholar
• Clayton A, Court J, Navabi H, et al. Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. J Immunol Methods. 2001;247(1–2):163–174. doi:10.1016/S0022-1759(00)00321-5
   PubMed Web of Science ®Google Scholar
• Momen-Heravi F, Balaj L, Alian S, et al. Alternative methods for characterization of extracellular vesicles. Front Physiol. 2012;3:354. doi:10.3389/fphys.2012.00354
   PubMed Web of Science ®Google Scholar
• Choi DS, Kim DK, Kim YK, Gho YS. Proteomics of extracellular vesicles: exosomes and ectosomes. Mass Spectrom Rev. 2015;34(4):474–490. doi:10.1002/mas.21420
   PubMed Web of Science ®Google Scholar
• Tang YT, Huang YY, Zheng L, et al. Comparison of isolation methods of exosomes and exosomal RNA from cell culture medium and serum. Int J Mol Med. 2017;40(3):834–844. doi:10.3892/ijmm.2017.3080
   PubMed Web of Science ®Google Scholar
• Tkach M, Théry C. Communication by Extracellular Vesicles: where We Are and Where We Need to Go. Cell. 2016;164(6):1226–1232. doi:10.1016/j.cell.2016.01.043
   PubMed Web of Science ®Google Scholar
• Schey KL, Luther JM, Rose KL. Proteomics characterization of exosome cargo. Methods. 2015;87:75–82. doi:10.1016/j.ymeth.2015.03.018
   PubMed Web of Science ®Google Scholar
• Wang YT, Shi T, Srivastava S, Kagan J, Liu T, Rodland KD. Proteomic Analysis of Exosomes for Discovery of Protein Biomarkers for Prostate and Bladder Cancer. Cancers. 2020;12(9):2335. doi:10.3390/cancers12092335
   PubMed Web of Science ®Google Scholar
• Iraci N, Gaude E, Leonardi T, et al. Extracellular vesicles are independent metabolic units with asparaginase activity. Nat Chem Biol. 2017;13(9):951–955. doi:10.1038/nchembio.2422
   PubMed Web of Science ®Google Scholar
• Li Y, Zheng Q, Bao C, et al. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res. 2015;25(8):981–984. doi:10.1038/cr.2015.82
   PubMed Web of Science ®Google Scholar
• Yang E, Wang X, Gong Z, Yu M, Wu H, Zhang D. Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression. Signal Transduct Target Ther. 2020;5(1):242. doi:10.1038/s41392-020-00359-5
   PubMed Web of Science ®Google Scholar
• Marar C, Starich B, Wirtz D. Extracellular vesicles in immunomodulation and tumor progression. Nat Immunol. 2021;22(5):560–570. doi:10.1038/s41590-021-00899-0
   PubMed Web of Science ®Google Scholar
• Kumar B, Garcia M, Weng L, et al. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion. Leukemia. 2018;32(3):575–587. doi:10.1038/leu.2017.259
   PubMed Web of Science ®Google Scholar
• Hu W, Liu C, Bi ZY, et al. Comprehensive landscape of extracellular vesicle-derived RNAs in cancer initiation, progression, metastasis and cancer immunology. Mol Cancer. 2020;19(1):102. doi:10.1186/s12943-020-01199-1
   PubMed Web of Science ®Google Scholar
• Madhavan B, Yue S, Galli U, et al. Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity. Int, J, Cancer. 2015;136(11):2616–2627. doi:10.1002/ijc.29324
   PubMed Web of Science ®Google Scholar
• Zhou W, Fong MY, Min Y, et al. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell. 2014;25(4):501–515. doi:10.1016/j.ccr.2014.03.007
   PubMed Web of Science ®Google Scholar
• Kugeratski FG, Kalluri R. Exosomes as mediators of immune regulation and immunotherapy in cancer. Febs j. 2021;288(1):10–35. doi:10.1111/febs.15558
   PubMed Web of Science ®Google Scholar
• Becker A, Thakur BK, Weiss JM, Kim HS, Peinado H, Lyden D. Extracellular Vesicles in Cancer: cell-to-Cell Mediators of Metastasis. Cancer Cell. 2016;30(6):836–848. doi:10.1016/j.ccell.2016.10.009
   PubMed Web of Science ®Google Scholar
• Jouida A, O’Callaghan M, Mc Carthy C, Fabre A, Nadarajan P, Keane MP. Exosomes from EGFR-Mutated Adenocarcinoma Induce a Hybrid EMT and MMP9-Dependant Tumor Invasion. Cancers. 2022;14(15):3776. doi:10.3390/cancers14153776
   PubMed Web of Science ®Google Scholar
• Qiu Z, Zhong Z, Zhang Y, Tan H, Deng B, Meng G. Human umbilical cord mesenchymal stem cell-derived exosomal miR-335-5p attenuates the inflammation and tubular epithelial-myofibroblast transdifferentiation of renal tubular epithelial cells by reducing ADAM19 protein levels. Stem Cell Res Ther. 2022;13(1):373. doi:10.1186/s13287-022-03071-z
   PubMed Web of Science ®Google Scholar
• Nabet BY, Qiu Y, Shabason JE, et al. Exosome RNA Unshielding Couples Stromal Activation to Pattern Recognition Receptor Signaling in Cancer. Cell. 2017;170(2):352–366.e313. doi:10.1016/j.cell.2017.06.031
   PubMed Web of Science ®Google Scholar
• Ristorcelli E, Beraud E, Mathieu S, Lombardo D, Verine A. Essential role of Notch signaling in apoptosis of human pancreatic tumoral cells mediated by exosomal nanoparticles. Int, J, Cancer. 2009;125(5):1016–1026. doi:10.1002/ijc.24375
   PubMed Web of Science ®Google Scholar
• Keller S, König AK, Marmé F, et al. Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes. Cancer Lett. 2009;278(1):73–81. doi:10.1016/j.canlet.2008.12.028
   PubMed Web of Science ®Google Scholar
• Franklin RA, Liao W, Sarkar A, et al. The cellular and molecular origin of tumor-associated macrophages. Science. 2014;344(6186):921–925. doi:10.1126/science.1252510
   PubMed Web of Science ®Google Scholar
• Chen Q, Li Y, Gao W, Chen L, Xu W, Zhu X. Exosome-Mediated Crosstalk Between Tumor and Tumor-Associated Macrophages. Front Mol Biosci. 2021;8:764222. doi:10.3389/fmolb.2021.764222
   PubMed Web of Science ®Google Scholar
• Yin Z, Zhou Y, Ma T, et al. Down-regulated lncRNA SBF2-AS1 in M2 macrophage-derived exosomes elevates miR-122-5p to restrict XIAP, thereby limiting pancreatic cancer development. J Cell Mol Med. 2020;24(9):5028–5038. doi:10.1111/jcmm.15125
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhu B, He M, et al. N6-Methylandenosine-Related lncRNAs Predict Prognosis and Immunotherapy Response in Bladder Cancer. Front Oncol. 2021;11:710767. doi:10.3389/fonc.2021.710767
   PubMed Web of Science ®Google Scholar
• Lu L, Ling W, Ruan Z. TAM-derived extracellular vesicles containing microRNA-29a-3p explain the deterioration of ovarian cancer. Mol Ther Nucleic Acids. 2021;25:468–482. doi:10.1016/j.omtn.2021.05.011
   PubMedGoogle Scholar
• Tang Z, Tang C, Sun C, Ying X, Shen R. M1 macrophage-derived exosomes synergistically enhance the anti- bladder cancer effect of gemcitabine. Aging (Albany NY). 2022;14(18):7364–7377. doi:10.18632/aging.204200
   PubMedGoogle Scholar
• Junker K, Heinzelmann J, Beckham C, Ochiya T, Jenster G. Extracellular Vesicles and Their Role in Urologic Malignancies. Eur Urol. 2016;70(2):323–331. doi:10.1016/j.eururo.2016.02.046
   PubMed Web of Science ®Google Scholar
• Wu CH, Silvers CR, Messing EM, Lee YF. Bladder cancer extracellular vesicles drive tumorigenesis by inducing the unfolded protein response in endoplasmic reticulum of nonmalignant cells. J Biol Chem. 2019;294(9):3207–3218. doi:10.1074/jbc.RA118.006682
   PubMed Web of Science ®Google Scholar
• Ogorevc E, Hudoklin S, Veranič P, Kralj-Iglič V. Extracellular vesicle-mediated transfer of membranous components from the highly malignant T24 urinary carcinoma cell line to the non-malignant RT4 urinary papilloma cell line. Protoplasma. 2014;251(3):699–702. doi:10.1007/s00709-013-0544-5
   PubMed Web of Science ®Google Scholar
• Georgantzoglou N, Pergaris A, Masaoutis C, Theocharis S. Extracellular Vesicles as Biomarkers Carriers in Bladder Cancer: diagnosis, Surveillance, and Treatment. Int J Mol Sci. 2021;22(5):2744. doi:10.3390/ijms22052744
   PubMed Web of Science ®Google Scholar
• Liu YR, Ortiz-Bonilla CJ, Lee YF. Extracellular Vesicles in Bladder Cancer: biomarkers and Beyond. Int J Mol Sci. 2018;19(9). doi:10.3390/ijms19092822
   Web of Science ®Google Scholar
• Mao W, Wang K, Wu Z, Xu B, Chen M. Current status of research on exosomes in general, and for the diagnosis and treatment of kidney cancer in particular. J Exp Clin Cancer Res. 2021;40(1):305. doi:10.1186/s13046-021-02114-2
   PubMed Web of Science ®Google Scholar
• Wood SL, Knowles MA, Thompson D, Selby PJ, Banks RE. Proteomic studies of urinary biomarkers for prostate, bladder and kidney cancers. Nat Rev Urol. 2013;10(4):206–218. doi:10.1038/nrurol.2013.24
   PubMed Web of Science ®Google Scholar
• Beckham CJ, Olsen J, Yin PN, et al. Bladder cancer exosomes contain EDIL-3/Del1 and facilitate cancer progression. J Urol. 2014;192(2):583–592. doi:10.1016/j.juro.2014.02.035
   PubMed Web of Science ®Google Scholar
• Song Q, Yu H, Cheng Y, et al. Bladder cancer-derived exosomal KRT6B promotes invasion and metastasis by inducing EMT and regulating the immune microenvironment. J Transl Med. 2022;20(1):308. doi:10.1186/s12967-022-03508-2
   PubMed Web of Science ®Google Scholar
• Surman M, Kędracka-Krok S, Jankowska U, Drożdż A, Stępień E, Przybyło M. Proteomic Profiling of Ectosomes Derived from Paired Urothelial Bladder Cancer and Normal Cells Reveals the Presence of Biologically-Relevant Molecules. Int J Mol Sci. 2021;22(13). doi:10.3390/ijms22136816
   PubMed Web of Science ®Google Scholar
• Abercrombie M. Contact inhibition and malignancy. Nature. 1979;281(5729):259–262. doi:10.1038/281259a0
   PubMed Web of Science ®Google Scholar
• Lin F, Yin HB, Li XY, Zhu GM, He WY, Gou X. Bladder cancer cell‑secreted exosomal miR‑21 activates the PI3K/AKT pathway in macrophages to promote cancer progression. Int J Oncol. 2020;56(1):151–164. doi:10.3892/ijo.2019.4933
   PubMed Web of Science ®Google Scholar
• Shan G, Zhou X, Gu J, et al. Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt/β-catenin pathway and upregulating PTEN. Cell Oncol Dordr. 2021;44(1):45–59. doi:10.1007/s13402-020-00500-0
   PubMed Web of Science ®Google Scholar
• Wu JH, Sun KN, Chen ZH, He YJ, Sheng L. Exosome-Mediated miR-4792 Transfer Promotes Bladder Cancer Cell Proliferation via Enhanced FOXC1/c-Myc Signaling and Warburg Effect. J Oncol. 2022;2022:5680353. doi:10.1155/2022/5680353
   PubMed Web of Science ®Google Scholar
• Li Q, Huyan T, Cai S, et al. The role of exosomal miR-375-3p: a potential suppressor in bladder cancer via the Wnt/β-catenin pathway. FASEB j. 2020;34(9):12177–12196. doi:10.1096/fj.202000347R
   PubMed Web of Science ®Google Scholar
• Yin X, Zheng X, Liu M, et al. Exosomal miR-663b targets Ets2-repressor factor to promote proliferation and the epithelial-mesenchymal transition of bladder cancer cells. Cell Biol Int. 2020;44(4):958–965. doi:10.1002/cbin.11292
   PubMed Web of Science ®Google Scholar
• Yan L, Li Q, Sun K, Jiang F. MiR-4644 is upregulated in plasma exosomes of bladder cancer patients and promotes bladder cancer progression by targeting UBIAD1. Am J Transl Res. 2020;12(10):6277–6289.
   PubMed Web of Science ®Google Scholar
• Liu Q. The emerging roles of exosomal long non-coding RNAs in bladder cancer. J Cell Mol Med. 2022;26(4):966–976. doi:10.1111/jcmm.17152
   PubMed Web of Science ®Google Scholar
• Mirzadeh Azad F, Polignano IL, Proserpio V, Oliviero S. Long Noncoding RNAs in Human Stemness and Differentiation. Trends Cell Biol. 2021;31(7):542–555. doi:10.1016/j.tcb.2021.02.002
   PubMed Web of Science ®Google Scholar
• Hu Q, Egranov SD, Lin C, Yang L. Long noncoding RNA loss in immune suppression in cancer. Pharmacol Ther. 2020;213:107591. doi:10.1016/j.pharmthera.2020.107591
   PubMed Web of Science ®Google Scholar
• Huang Z, Zhou JK, Peng Y, He W, Huang C. The role of long noncoding RNAs in hepatocellular carcinoma. Mol Cancer. 2020;19(1):77. doi:10.1186/s12943-020-01188-4
   PubMed Web of Science ®Google Scholar
• Liu K, Gao L, Ma X, et al. Long non-coding RNAs regulate drug resistance in cancer. Mol Cancer. 2020;19(1):54. doi:10.1186/s12943-020-01162-0
   PubMed Web of Science ®Google Scholar
• Tong Y, Liu X, Xia D, et al. Biological Roles and Clinical Significance of Exosome-Derived Noncoding RNAs in Bladder Cancer. Front Oncol. 2021;11:704703. doi:10.3389/fonc.2021.704703
   PubMed Web of Science ®Google Scholar
• Fan Y, Shen B, Tan M, et al. Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling. Febs j. 2014;281(7):1750–1758. doi:10.1111/febs.12737
   PubMed Web of Science ®Google Scholar
• Pan J, Li X, Wu W, et al. Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells. Cancer Lett. 2016;382(1):64–76. doi:10.1016/j.canlet.2016.08.015
   PubMed Web of Science ®Google Scholar
• Wang X, Gao Z, Liao J, et al. lncRNA UCA1 inhibits esophageal squamous-cell carcinoma growth by regulating the Wnt signaling pathway. J Toxicol Environ Health A. 2016;79(9–10):407–418. doi:10.1080/15287394.2016.1176617
   PubMed Web of Science ®Google Scholar
• Wu W, Zhang S, Li X, Xue M, Cao S, Chen W. Ets-2 regulates cell apoptosis via the Akt pathway, through the regulation of urothelial cancer associated 1, a long non-coding RNA, in bladder cancer cells. PLoS One. 2013;8(9):e73920. doi:10.1371/journal.pone.0073920
   PubMed Web of Science ®Google Scholar
• Yang C, Li X, Wang Y, Zhao L, Chen W. Long non-coding RNA UCA1 regulated cell cycle distribution via CREB through PI3-K dependent pathway in bladder carcinoma cells. Gene. 2012;496(1):8–16. doi:10.1016/j.gene.2012.01.012
   PubMed Web of Science ®Google Scholar
• Xue M, Chen W, Xiang A, et al. Hypoxic exosomes facilitate bladder tumor growth and development through transferring long non-coding RNA-UCA1. Mol Cancer. 2017;16(1):143. doi:10.1186/s12943-017-0714-8
   PubMed Web of Science ®Google Scholar
• Xue M, Pang H, Li X, Li H, Pan J, Chen W. Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway. Cancer Sci. 2016;107(1):18–27. doi:10.1111/cas.12844
   PubMed Web of Science ®Google Scholar
• Zheng R, Du M, Wang X, et al. Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression. Mol Cancer. 2018;17(1):143. doi:10.1186/s12943-018-0880-3
   PubMed Web of Science ®Google Scholar
• Chen C, Luo Y, He W, et al. Exosomal long noncoding RNA LNMAT2 promotes lymphatic metastasis in bladder cancer. J Clin Invest. 2020;130(1):404–421. doi:10.1172/JCI130892
   PubMed Web of Science ®Google Scholar
• Zheng H, Chen C, Luo Y, et al. Tumor-derived exosomal BCYRN1 activates WNT5A/VEGF-C/VEGFR3 feedforward loop to drive lymphatic metastasis of bladder cancer. Clin Transl Med. 2021;11(7):e497. doi:10.1002/ctm2.497
   PubMed Web of Science ®Google Scholar
• Greening DW, Gopal SK, Xu R, Simpson RJ, Chen W. Exosomes and their roles in immune regulation and cancer. Semin Cell Dev Biol. 2015;40:72–81. doi:10.1016/j.semcdb.2015.02.009
   PubMed Web of Science ®Google Scholar
• Lee N, Canagasingham A, Bajaj M, et al. Urine exosomes as biomarkers in bladder cancer diagnosis and prognosis: from functional roles to clinical significance. Front Oncol. 2022;12:1019391. doi:10.3389/fonc.2022.1019391
   PubMed Web of Science ®Google Scholar
• Lopez-Beltran A, Cheng L, Gevaert T, et al. Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers. Expert Rev Mol Diagn. 2020;20(2):231–243. doi:10.1080/14737159.2020.1699791
   PubMed Web of Science ®Google Scholar
• Ng K, Stenzl A, Sharma A, Vasdev N. Urinary biomarkers in bladder cancer: a review of the current landscape and future directions. Urol Oncol. 2021;39(1):41–51. doi:10.1016/j.urolonc.2020.08.016
   PubMed Web of Science ®Google Scholar
• Matuszczak M, Kiljańczyk A, Salagierski M. A Liquid Biopsy in Bladder Cancer-The Current Landscape in Urinary Biomarkers. Int J Mol Sci. 2022;23(15):8597. doi:10.3390/ijms23158597
   PubMed Web of Science ®Google Scholar
• Kalluri R. The biology and function of exosomes in cancer. J Clin Invest. 2016;126(4):1208–1215. doi:10.1172/JCI81135
   PubMed Web of Science ®Google Scholar
• Welton JL, Khanna S, Giles PJ, et al. Proteomics analysis of bladder cancer exosomes. Mol Cell Proteomics. 2010;9(6):1324–1338. doi:10.1074/mcp.M000063-MCP201
   PubMed Web of Science ®Google Scholar
• Chen YT, Chen CL, Chen HW, et al. Discovery of novel bladder cancer biomarkers by comparative urine proteomics using iTRAQ technology. J Proteome Res. 2010;9(11):5803–5815. doi:10.1021/pr100576x
   PubMed Web of Science ®Google Scholar
• Li H, Li C, Wu H, et al. Identification of Apo-A1 as a biomarker for early diagnosis of bladder transitional cell carcinoma. Proteome Sci. 2011;9(1):21. doi:10.1186/1477-5956-9-21
   PubMedGoogle Scholar
• Orenes-Piñero E, Cortón M, González-Peramato P, et al. Searching urinary tumor markers for bladder cancer using a two-dimensional differential gel electrophoresis (2D-DIGE) approach. J Proteome Res. 2007;6(11):4440–4448. doi:10.1021/pr070368w
   PubMed Web of Science ®Google Scholar
• Güllü Amuran G, Tinay I, Filinte D, Ilgin C, Peker Eyüboğlu I, Akkiprik M. Urinary micro-RNA expressions and protein concentrations may differentiate bladder cancer patients from healthy controls. Int Urol Nephrol. 2020;52(3):461–468. doi:10.1007/s11255-019-02328-6
   PubMed Web of Science ®Google Scholar
• Yazarlou F, Modarressi MH, Mowla SJ, et al. Urinary exosomal expression of long non-coding RNAs as diagnostic marker in bladder cancer. Cancer Manag Res. 2018;10:6357–6365. doi:10.2147/CMAR.S186108
   PubMed Web of Science ®Google Scholar
• Shi Y, Mathis BJ, He Y, Yang X. The Current Progress and Future Options of Multiple Therapy and Potential Biomarkers for Muscle-Invasive Bladder Cancer. Biomedicines. 2023;11(2):539. doi:10.3390/biomedicines11020539
   PubMed Web of Science ®Google Scholar
• Yu D, Li Y, Wang M, et al. Exosomes as a new frontier of cancer liquid biopsy. Mol Cancer. 2022;21(1):56. doi:10.1186/s12943-022-01509-9
   PubMed Web of Science ®Google Scholar
• He L, Zhu D, Wang J, Wu X. A highly efficient method for isolating urinary exosomes. Int J Mol Med. 2019;43(1):83–90. doi:10.3892/ijmm.2018.3944
   PubMed Web of Science ®Google Scholar
• Gavas S, Quazi S, Karpiński TM. Nanoparticles for Cancer Therapy: current Progress and Challenges. Nanoscale Res Lett. 2021;16(1):173. doi:10.1186/s11671-021-03628-6
   PubMed Web of Science ®Google Scholar
• Hao Y, Ji Z, Zhou H, et al. Lipid-based nanoparticles as drug delivery systems for cancer immunotherapy. MedComm. 2023;4(4):e339. doi:10.1002/mco2.339
   PubMedGoogle Scholar
• Liao Z, Tu L, Li X, Liang XJ, Huo S. Virus-inspired nanosystems for drug delivery. Nanoscale. 2021;13(45):18912–18924. doi:10.1039/D1NR05872J
   PubMed Web of Science ®Google Scholar
• Zhang P, Chen Y, Zeng Y, et al. Virus-mimetic nanovesicles as a versatile antigen-delivery system. Proc Natl Acad Sci U S A. 2015;112(45):E6129–6138. doi:10.1073/pnas.1505799112
   PubMed Web of Science ®Google Scholar
• Thompson CA, Purushothaman A, Ramani VC, Vlodavsky I, Sanderson RD. Heparanase regulates secretion, composition, and function of tumor cell-derived exosomes. J Biol Chem. 2013;288(14):10093–10099. doi:10.1074/jbc.C112.444562
   PubMed Web of Science ®Google Scholar
• Bobrie A, Krumeich S, Reyal F, et al. Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression. Cancer Res. 2012;72(19):4920–4930. doi:10.1158/0008-5472.CAN-12-0925
   PubMed Web of Science ®Google Scholar
• Ramani VC, Purushothaman A, Stewart MD, et al. The heparanase/syndecan-1 axis in cancer: mechanisms and therapies. Febs j. 2013;280(10):2294–2306. doi:10.1111/febs.12168
   PubMed Web of Science ®Google Scholar
• Taverna S, Giallombardo M, Pucci M, et al. Curcumin inhibits in vitro and in vivo chronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21. Oncotarget. 2015;6(26):21918–21933. doi:10.18632/oncotarget.4204
   PubMedGoogle Scholar
• Chen L, Brigstock DR. Integrins and heparan sulfate proteoglycans on hepatic stellate cells (HSC) are novel receptors for HSC-derived exosomes. FEBS Lett. 2016;590(23):4263–4274. doi:10.1002/1873-3468.12448
   PubMed Web of Science ®Google Scholar
• Christianson HC, Svensson KJ, van Kuppevelt TH, Li JP, Belting M. Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity. Proc Natl Acad Sci U S A. 2013;110(43):17380–17385. doi:10.1073/pnas.1304266110
   PubMed Web of Science ®Google Scholar
• Zhang S, Guo M, Guo T, et al. DAL-1/4.1B promotes the uptake of exosomes in lung cancer cells via Heparan Sulfate Proteoglycan 2 (HSPG2). Mol Cell Biochem. 2022;477(1):241–254. doi:10.1007/s11010-021-04268-1
   PubMed Web of Science ®Google Scholar
• Vader P, Mol EA, Pasterkamp G, Schiffelers RM. Extracellular vesicles for drug delivery. Adv Drug Deliv Rev. 2016;106(Pt A):148–156. doi:10.1016/j.addr.2016.02.006
   PubMed Web of Science ®Google Scholar
• Palazzolo S, Memeo L, Hadla M, et al. Cancer Extracellular Vesicles: next-Generation Diagnostic and Drug Delivery Nanotools. Cancers. 2020;12(11):3165. doi:10.3390/cancers12113165
   PubMed Web of Science ®Google Scholar
• Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011;29(4):341–345. doi:10.1038/nbt.1807
   PubMed Web of Science ®Google Scholar
• Saari H, Lázaro-Ibáñez E, Viitala T, Vuorimaa-Laukkanen E, Siljander P, Yliperttula M. Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells. J Control Release. 2015;220(Pt B):727–737. doi:10.1016/j.jconrel.2015.09.031
   PubMed Web of Science ®Google Scholar
• Li YJ, Wu JY, Wang JM, Hu XB, Cai JX, Xiang DX. Gemcitabine loaded autologous exosomes for effective and safe chemotherapy of pancreatic cancer. Acta Biomater. 2020;101:519–530. doi:10.1016/j.actbio.2019.10.022
   PubMed Web of Science ®Google Scholar